90 related articles for article (PubMed ID: 25249600)
1. Role of metallothioneins 1 and 2 in ocular neovascularization.
Nakamura S; Shimazawa M; Inoue Y; Takata S; Ito Y; Tsuruma K; Ikeda T; Honda A; Satoh M; Hara H
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6851-6860. PubMed ID: 25249600
[TBL] [Abstract][Full Text] [Related]
2. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
3. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
4. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
5. Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.
Lin M; Hu Y; Chen Y; Zhou KK; Jin J; Zhu M; Le YZ; Ge J; Ma JX
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6197-206. PubMed ID: 22915031
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model.
Zhang ZX; Wang YS; Shi YY; Hou HY; Zhang C; Cai Y; Dou GR; Yao LB; Li FY
Curr Eye Res; 2011 Sep; 36(9):838-49. PubMed ID: 21851170
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
10. Endothelial TWIST1 promotes pathological ocular angiogenesis.
Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
13. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
14. Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model.
Vavilala DT; O'Bryhim BE; Ponnaluri VK; White RS; Radel J; Symons RC; Mukherji M
Biochem Biophys Res Commun; 2013 Sep; 438(4):697-702. PubMed ID: 23921228
[TBL] [Abstract][Full Text] [Related]
15. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
16. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
[TBL] [Abstract][Full Text] [Related]
17. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
18. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
Song SJ; Chung H; Yu HG
Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.
Ozaki H; Yu AY; Della N; Ozaki K; Luna JD; Yamada H; Hackett SF; Okamoto N; Zack DJ; Semenza GL; Campochiaro PA
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):182-9. PubMed ID: 9888442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
